Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Spinomenal Strikes Gold with Magical Leprechaun Release

Leading iGaming content provider Spinomenal is celebrating the upcoming St Patrick’s Day celebrations with its Magical Leprechaun.This Irish-inspired title sits within a 5x3 design, offers 10 pay lines and features a host of classically Irish symbols. On the reels players will discover pots bursting with gold, a resplendent shamrock hat, lucky golden horseshoes and of course, the famous four-leaf clover. A toe-tapping, fun soundtrack helps build the atmosphere on the reels as players go on the hunt for big returns. A mischievous leprechaun represents the Wild symbol on the reels and will

Form 8.3 - Mondi Plc

FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)   1. KEY INFORMATION   +----------------------------------------------------------+-----------------+|(a) Full name of discloser: |Ninety One UK Ltd|+----------------------------------------------------------+-----------------+|(b) Owner or controller of interests and short positions |  ||disclosed, if different from 1(a):

Wirtek changes Certified Advisor

Company announcement no. 2/20244 March 2024   As of 1 March 2024, Wirtek has changed Certified Advisor to Grant Thornton. Further information · Michael Aaen, CEO, Wirtek A/S, Phone: +45 2529 7575, E-mail: ir@wirtek.comNiels Jernes Vej 10, 9220 Aalborg Ø, www.wirtek.com · Kent Mousten Sørensen, Chairman, Wirtek A/S, Phone: +45 2125 9001 · Mads Riis Møller, Certified Advisor, Grant Thornton, Phone: +45 3311 0220 About Wirtek Wirtek A/S is a Danish IT consultancy company that provides software development, testing, and consultancy services to help clients

Saab starts construction of new Carl-Gustaf factory in India

Saab has today marked the start of the construction of its new Carl-Gustaf[®] manufacturing facility in India with a ground breaking ceremony. The factory will be located in the state of Haryana.After receiving approval of 100% foreign direct investment, Saab has established a new company, Saab FFVO India Pvt Ltd, which will fully own the new manufacturing facility and produce the Carl-Gustaf M4 weapon. “I am proud to start constructing our first facility outside Sweden for Carl-Gustaf, a product that has a long history with the Indian Armed Forces. We look forward to starting production

Invitation Boliden’s Virtual Capital Markets Update

Boliden is pleased to invite investors, analysts and financial media to our virtual Capital Markets Update on March 18, 2024 at 14:00-16:00 CET. The digital event includes a business update and an update on key projects with the opportunity to ask questions. Boliden will be represented by President and CEO, Mikael Staffas together with members of the Group Management. You are welcome to follow the live webcast at Boliden’s website www.boliden.com. The presentations will be followed by a Q&A session where participants have the opportunity to post questions via the webcast chat or by

Optomed Plc - Managers' transactions - Knuutti

Optomed Plc - Managers' Transactions – 4 March 2024 at 12.00 EET Optomed Plc - Managers' transactions - Knuutti ____________________________________________ Person subject to the notification requirement Name: Knuutti, Sakari Position: Chief Financial Officer Issuer: Optomed Plc LEI: 7437009IVYWGEE4S7B77 Notification type: INITIAL NOTIFICATION Reference number: 7437009IVYWGEE4S7B77_20240229141829_28 ____________________________________________ Transaction date: 2024-02-29 Venue not applicable Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A

Optomed Plc - Managers' transactions - Myllylä

Optomed Plc - Managers' Transactions – 4 March  2024 at 12.00 EET Optomed Plc - Managers' transactions - Myllylä ____________________________________________ Person subject to the notification requirement Name: Myllylä, Markku Position: Other senior manager Issuer: Optomed Plc LEI: 7437009IVYWGEE4S7B77 Notification type: INITIAL NOTIFICATION Reference number: 7437009IVYWGEE4S7B77_20240229141829_27 ____________________________________________ Transaction date: 2024-02-29 Venue not applicable Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A

Optomed Plc - Managers' transactions - Piila

Optomed Plc - Managers' Transactions – 4 March 2024 at 12.00 EET Optomed Plc - Managers' transactions - Piila ____________________________________________ Person subject to the notification requirement Name: Piila, Laura Position: Other senior manager Issuer: Optomed Plc LEI: 7437009IVYWGEE4S7B77 Notification type: INITIAL NOTIFICATION Reference number: 7437009IVYWGEE4S7B77_20240229141829_26 ____________________________________________ Transaction date: 2024-02-29 Venue not applicable Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT

Optomed Plc - Managers' transactions - Himberg

Optomed Plc - Managers' Transactions – 4 March  2024 at 12.00 EET Optomed Plc - Managers' transactions - Himberg ____________________________________________ Person subject to the notification requirement Name: Himberg, Juho-Pekka Position: Chief Executive Officer Issuer: Optomed Plc LEI: 7437009IVYWGEE4S7B77 Notification type: INITIAL NOTIFICATION Reference number: 7437009IVYWGEE4S7B77_20240229141829_25 ____________________________________________ Transaction date: 2024-02-29 Venue not applicable Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE

Acquisitions of own shares in Evolution AB (publ)

Evolution AB (publ) (“Evolution”) has, during the period 26 February – 01 March acquired a total of 208,500 own shares within the framework of the repurchase programme introduced by the board of directors to improve the capital structure of Evolution by reducing the capital, and thereby creating added shareholder value.The repurchase programme, which Evolution announced on 23 November 2023, is being implemented in accordance with the EU Market Abuse Regulation No 596/2014 (“MAR”) and Commission Delegated Regulation No 2016/1052 (“Safe Harbour Regulation”). During the period 26 February –

Change of Service Providers

LEI: 21380048Q8UABVMAG916   MITON UK MICROCAP TRUST PLC (the “Company”) Change of Service Providers - Confirmation   Further to the announcement made by Miton UK Microcap Trust plc on 22nd November 2023, the Company confirms that the following appointments came into effect from 4th March 2024: · Northern Trust Secretarial Services (UK) Limited was appointed as Company Secretary. · Northern Trust Investor Services Limited was appointed as Depositary. · Premier Portfolio Managers Limited was appointed as fund administrator.  Fund administration services have been

Bulletin from Extraordinary General Meeting in Tobii AB (publ)

Tobii AB (publ) held an Extraordinary General Meeting on March 4, 2024, which, inter alia, authorized the Board of Directors to resolve on the issue of ordinary shares for the execution of the fully guaranteed rights issue.The Extraordinary General Meeting was conducted with the physical presence of shareholders and with the possibility for shareholders to exercise their voting rights through advance voting (postal voting). The Extraordinary General Meeting resolved on the following: Resolution regarding amendment to the Articles of Association The Extraordinary General Meeting

BioStock: Comments from Orphazyme on the investment in CombiGene

Orphazyme has acquired 10 per cent of the shares in CombiGene, making the Danish investment company one of the largest shareholders. BioStock reached out to Orphazyme’s Chairman of the Board Michael Hove and CombiGene’s CEO Peter Ekolind to learn more about the reasons for the investment.Read the full interview with Michael Hove and Peter Ekolind at biostock.se: https://www.biostock.se/en/2024/03/comments-from-orphazyme-on-the-investment-in-combigene/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/

Nordic Mining ASA: New share capital registered - 5 shares

Reference is made to the stock exchange announcement on 1 March 2024 regarding the resolution by the Board of Directors to increase the Company’s share capital by issuance of 5 shares. The new share capital has today been registered with the Norwegian Register of Business Enterprises (Nw.: Foretaksregisteret). The Company`s share capital has been increased by NOK 3 by the issuance of 5 new shares. The Company's new share capital is NOK 1 300 938 396 divided on 2 168 230 660 shares, each with a nominal value of NOK 0.60. Each share carries one vote. For further information, please

DZ Bank AG: Post-Stabilisation Notice

DZ Bank AG: Post-Stabilisation Notice Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful. DZ BANK AG (contact: Ralph Ockert; telephone: +49 69 7447 7051) herebygives notice that no stabilisation (within the meaning of Article 3.2 (d) of the Market Abuse Regulation (EU Regulation 596/2014) was undertaken by the Stabilising Managers named below in relation to the offer of the following securities. The security to be stabilised:    Issuer:                           Metro AG    Guarantor (

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 51 – 4 MARTS 2024   In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcements nos. 30/24 and 31/24.   Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Stig Frederiksen, Head of Communications & Investor Relations, tel.: +45 32 71 08 55, e-mail: sfr@norden.com

Dampskibsselskabet NORDEN A/S – weekly report on share buy-back

ANNOUNCEMENT NO. 50 – 4 MARCH 2024   On 8 February 2024, NORDEN initiated a share buy-back programme in accordance with Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and Commission Delegated Regulation (EU) 2016/1052, (Safe Harbour regulation). The share buy-back programme runs from 9 February 2024 up to and including no later than 19 April 2024. For details, please see announcement no. 30 of 8 February 2024.   Under the share buy-back programme, NORDEN will purchase shares for up to a total of USD 15 million (approximately DKK 105 million)

Telia announces a tender offer in respect of certain outstanding SEK and EUR notes

Not for distribution, directly or indirectly, in or into or to any person located or resident in the United States, its territories and possessions (including Puerto Rico, the U.S. Virgin Islands, Guam, American Samoa, Wake Island and the Northern Mariana Islands), any state of the United States or the District of Columbia or in or into any other jurisdiction where it is unlawful to distribute this announcement. Telia Company AB (“Telia”) has today announced an invitation to holders of its outstanding SEK 600,000,000 3.995 per cent. Notes due 7 November 2024 (XS2553184461), SEK 2,400,000,

Karolinska University Hospital among the first in Europe to introduce new robotic surgery

For more than 20 years, Karolinska University Hospital has been using robotic surgery. Now the hospital will be one of the first in Europe to use a new robot. It uses a technology that can make a big difference for a group of patients.At Karolinska University Hospital, robots are already making a major contribution to cancer surgery. Each year, surgeons use them in around 1,300–1,400 procedures. The robots that are currently available at Karolinska use a technology called multiport. During surgery, the robot makes a hole in the patient for the camera and other holes for the instruments.

The new shares of NoHo Partners Plc have been registered into the Trade Register and the book-entry system of Euroclear Finland Oy

NoHo Partners Plc, Stock Exchange Release 4 March 2024 at 10:40The new shares of NoHo Partners Plc have been registered into the Trade Register and the book-entry system of Euroclear Finland Oy The Board of Directors of NoHo Partners Plc has on 28 February 2024 resolved on a directed share issue without payment to the CEO of the company and to the deputy of the CEO in order to pay the delayed earned reward for the third earning period that ended on 31 March 2023 of the long-term share-based incentive plan. The stock exchange release concerning the directed share issue without payment

Medivir to present at the Life Science Day in Gothenburg on March 6

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announces that the company will participate at the Life Science Day in Gothenburg on March 6, 2024.  CEO Jens Lindberg will present Medivir with focus on data from the ongoing Phase 1b/2a clinical trial with fostroxacitabine bralpamide (fostrox) and how these data enable an acceleration of fostrox's development program.   Medivir's presentation starts at 09.45 CET and can be viewed live on www.

Qred strengthens its senior management team with two new talents

Qred, Europe’s newest bank for small businesses, is pleased to announce Dhanush Raja Lakshmanmurthy as its new Chief Marketing Officer (CMO) and Amanda Gormaz as Chief Human Resources Officer (CHRO) Stockholm, March 4, 2024 - Qred is today announcing the appointment of two additions to its senior management. Dhanush Raja Lakshmanmurthy as the new CMO, and Amanda Gormaz as CHRO.  Dhanush came most recently from Zettle by PayPal, where he operated as Brand Marketing Manager. Dhanush started his journey at Qred as Head of Digital Marketing and later stepped up as interim CMO in

Tero Tynkkynen appointed interim Chief Commercial Officer for Fazer Group

Tero Tynkkynen (b. 1969) has been appointed interim Chief Commercial Officer and member of Fazer’s Leadership Team as of 1 March 2024. He will lead the newly established Group Commercial Organisation on an interim basis until the ongoing recruitment process for the permanent Chief Commercial Officer has been finalised.Tero Tynkkynen joins Fazer from Futuoffice Oy, where he has worked as Senior Vice President of Business Development. Prior to that, he had a long career at both Amer Sports and Procter & Gamble, where he held various executive leadership positions. "Tero has an extensive

Notice of Extraordinary General Meeting in Samhällsbyggnadsbolaget i Norden AB (publ)

The shareholders of Samhällsbyggnadsbolaget i Norden AB (publ), reg. no 556981-7660, (the ”Company” or ”SBB”) are hereby given notice to attend the Extraordinary General Meeting on Wednesday, March 27, 2024, at 11:00. The General Meeting will be held at Wistrand Advokatbyrå’s premises, Regeringsgatan 65 in Stockholm, Sweden. Entrance and registration take place from 10:30.   Exercise of the right to vote Shareholders who wish to exercise their voting rights at the General Meeting must   · be recorded in the share register maintained by Euroclear Sweden AB relating to the

There are no items matching the current filter
There are no more items matching the current filter
Back to top